KODIAK SCIENCES
Kodiak Sciences is designing and developing novel therapies for the treatment of retinal disease. As a rapidly growing biopharmaceutical company, we are working every day to build value for the benefit of our community of patients, physicians, employees, families, and vendors. We want to have real impact, and we take a long term view. We are committed to ethics and excellence in everything we do. We are looking to hire top talent comfortable with ownership and accountability of exciting programs while collaborating effectively with colleagues inside and outside the company.
KODIAK SCIENCES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2009-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.kodiak.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.03 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics Apache
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Amblyotech
Amblyotech is the developer of novel electronic media therapies designed for the treatment of Amblyopia and other ocular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Azafaros
Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Gene Sciences, Inc.
Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.
Mavalon Therapeutics
Mavalon is developing drugs to stop the progression of Parkinson's disease.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Sernova
Sernova develops regenerative medicine therapeutic technologies for treatment of chronic metabolic diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Convertible Note - Kodiak Sciences
Rivas Capital
Rivas Capital investment in Convertible Note - Kodiak Sciences
ArrowMark Partners
ArrowMark Partners investment in Convertible Note - Kodiak Sciences
Official Site Inspections
http://www.kodiak.com Semrush global rank: 3.48 M Semrush visits lastest month: 4.34 K
- Host name: 192.0.66.176
- IP address: 192.0.66.176
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
